Skip to main content
. Author manuscript; available in PMC: 2019 Sep 18.
Published in final edited form as: Biochem Biophys Res Commun. 2018 Aug 11;503(4):2639–2645. doi: 10.1016/j.bbrc.2018.08.016

Fig. 3.

Fig. 3.

Ubiquinol-mediated blockade of astroglial and microglial activation in the transient ischemic retina. (A) Triple whole-mount immunohistochemistry for Brn3a, GFAP, and Iba-1 in ischemic retinas. Representative images with higher magnification showed a preservation of astroglial and microglial activation in the GCL of the ubiquinol-treated ischemic retina. Scale bars, 50 μm. (B and C) Quantification analyses of the intensity of GFAP immunoreactivity and the number of Iba-1-positive microglial cells. Values are mean ± SD (n = 5 images/group). Significant at *P < 0.05; **P < 0.01; *** P < 0.001compared with control diet-treated nonischemic control retina or control diet-treated ischemic retina.